Madison Elsaadi
Stock Analyst at B. Riley Securities
(4.75)
# 640
Out of 4,969 analysts
63
Total ratings
59.2%
Success rate
44.2%
Average return
Main Sectors:
Stocks Rated by Madison Elsaadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAPR Capricor Therapeutics | Upgraded: Buy | $5 → $21 | $8.81 | +138.37% | 8 | Sep 14, 2026 | |
| STIM Neuronetics | Initiated Coverage: Buy | $5 | $2.91 | +72.12% | 1 | Sep 11, 2026 | |
| VNDA Vanda Pharmaceuticals | Initiated Coverage: Buy | $17 → $12 | $5.15 | +133.01% | 6 | Aug 10, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $17 → $22 | $14.54 | +51.31% | 2 | Aug 6, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $123 | $80.67 | +52.47% | 7 | Aug 5, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $31 → $22 | $4.58 | +380.35% | 15 | Jul 31, 2026 | |
| SPRB Spruce Biosciences | Initiated Coverage: Buy | $160 | $56.85 | +181.44% | 1 | Jul 13, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $40 | $57.62 | -30.58% | 14 | Jun 25, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $5 | $2.74 | +82.48% | 4 | May 13, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $9 → $10 | $5.97 | +67.50% | 2 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $10.72 | +49.25% | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $179 | $216.58 | -17.35% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $7.13 | n/a | 1 | Jan 23, 2025 |
Capricor Therapeutics
Sep 14, 2026
Upgraded: Buy
Price Target: $5 → $21
Current: $8.81
Upside: +138.37%
Neuronetics
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.91
Upside: +72.12%
Vanda Pharmaceuticals
Aug 10, 2026
Initiated Coverage: Buy
Price Target: $17 → $12
Current: $5.15
Upside: +133.01%
COMPASS Pathways
Aug 6, 2026
Reiterated: Buy
Price Target: $17 → $22
Current: $14.54
Upside: +51.31%
Arrowhead Pharmaceuticals
Aug 5, 2026
Reiterated: Buy
Price Target: $123
Current: $80.67
Upside: +52.47%
Wave Life Sciences
Jul 31, 2026
Reiterated: Buy
Price Target: $31 → $22
Current: $4.58
Upside: +380.35%
Spruce Biosciences
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $56.85
Upside: +181.44%
Eton Pharmaceuticals
Jun 25, 2026
Reiterated: Buy
Price Target: $40
Current: $57.62
Upside: -30.58%
Ovid Therapeutics
May 13, 2026
Reiterated: Buy
Price Target: $5
Current: $2.74
Upside: +82.48%
Opus Genetics
Apr 30, 2026
Reiterated: Buy
Price Target: $9 → $10
Current: $5.97
Upside: +67.50%
Feb 12, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $10.72
Upside: +49.25%
Oct 1, 2025
Initiated Coverage: Buy
Price Target: $179
Current: $216.58
Upside: -17.35%
Jan 23, 2025
Reiterated: Buy
Price Target: $11
Current: $7.13
Upside: n/a